ERBB2 and breast ductal adenocarcinoma: Most of the patients were Malay (58.1%), married (82.7%), had ductal carcinoma (89.1%), ER and PR positive (59.6%), HER2 negative (62.4%), at T2-(51.9%), had received chemotherapy (70.9%) and had received radiotherapy (64.7%).